OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC ,   Russia

Tablets of 5 mg and 10 mg.

Film coated tablets, 25 mg, 50 mg and 100 mg.

Tablets, film-coated 10 mg, 20 mg, 40 mg, 80 mg.

Capsules 50 mg and 100 mg.

Tablets, coated with enteric coating, 5 mg.

Film coated tablets, 2.5 mg, 5 mg and 10 mg.

The coated tablets are 4 mg and 8 mg.

Tablets, 150 mg.

Tablets, film-coated, 40 mg and 80 mg.

Tablets, film-coated, 1000 mg.

Tablets of 25 mg.

Tablets coated with a film coating, 50 mg and 200 mg.

Film-coated tablets, 25 mg.

Tablets are chewable.

Tablets 80 mg.

Tablets of 40 mg.

Capsules of prolonged action, 200 mg.

Capsules, 100 mg.

Tablets of prolonged action, film-coated, 1.5 mg.

Capsules, 2.5 mg.

Tablets, film-coated, 50 mg.

Tablets are 100 μg and 200 μg.

Tablets chewing (apple) 500 mg + 200 ME and (orange) 500 mg + 400 ME.

Tablets of 50 mg.

Tablets 200 mg.

Tablets of 6.25 mg, 12.5 mg and 25 mg.

Capsules 295 mg.

Film-coated tablets, 25 mg, 100 mg and 200 mg.

The tablets covered with a cover, on 10 mg.

Tablets, 1 mg.

Tablets of prolonged action, coated with a coating, 500 mg.

Tablets, film-coated, 250 and 500 mg each.

Capsules 120 mg.

Capsules of 60 mg.

Capsules of 60 mg.

Tablets, film-coated, 10 mg and 20 mg.

Tablets, film-coated, 400 mg.

Tablets, film-coated, 1.5 mg, 3 mg.

Tablets, 7.5 mg and 15 mg.

Tablets of prolonged action, film-coated, 25 mg, 50 mg and 100 mg.

Tablets, film-coated, 2.5 mg.

Tablets, 0.25 mg and 1 mg.

Granules for the preparation of the suspension for ingestion 100 mg.

Tablets of 100 mg.

By 10, 15, 20, 30 tablets into a contour cell pack of film

polyvinylchloride and aluminum foil printed lacquered.

For 1, 2, 3, 4, 5, 6 contour mesh packages together with instructions for use in a pack of cardboard.

Tablets 10 mg.

Capsules, 100 mg and 200 mg.

Coated tablets, 10 mg.

Capsules 20 mg

Tablets coated with a film coating of 500 mg.

Powder for solution for oral administration (orange, cherry, caramel) 500 mg + 150 mg.

Powder for solution for oral administration (orange, cherry, caramel) 120 mg + 10 mg.

Tablets, film-coated 10 mg.

Intestine-soluble film coated tablets, 100 mg.

For 10 or 20 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

By 1, 2, 3 or 6 contour mesh packages with instructions for use in a pack of cardboard.

Capsules 10 mg, 20 mg.

Capsules intestine soluble 10 mg.

Capsules 30 mg, 40 mg.

By 7, 8, 10, 14, 28 capsules in the contour cell pack of film polyvinylchloride and aluminum foil printed lacquered.

By 56.112 or 224 capsules in a polymer or glass jar.

According to 1, 2, 3, 4, 5, 6, 7, 8 contour mesh packs or 1 bank together with instructions for use are placed in a pack of cardboard.

Capsules 250 mg.

Tablets 10 mg and 20 mg.

For 10 tablets in a contour mesh package made of a polyvinyl chloride film and foil of aluminum printed lacquered.

By 3, 5, 6 or 10 contour mesh packages together with instructions for usein a pack of cardboard.

Capsules with a modified release of 0.4 mg.

10, 14, 15, 20 capsules in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

For 1, 2, 3 contour squares, together with instructions for use, are placed in a pack of cardboard.

Tablets, 250 mg.

Capsules 250 mg.

Capsules 250 mg.

Tablets, film-coated, 20 mg and 40 mg.

Tablets, film-coated, 5 mg.

Capsules of 50 and 150 mg.

Powder for solution for ingestion (lemon, orange).

For 1, 2 or 3 contour squares, together with instructions for medical use, are placed in a pack of cardboard.

Capsules 25 mg and 50 mg.

Tablets coated with a coating, 500 mg.

The tablets covered with a cover, 250 mg.

Film-coated tablets.

Tablets 12.5 mg + 10 mg, 12.5 mg + 20 mg, 25 mg + 10 mg.

Tablets of 5 mg, 10 mg and 20 mg.

Powder for the preparation of a suspension for oral administration [orange, vanilla], 3 g.

Film coated tablets, 250 mg, 500 mg and 1000 mg.